)
)
)
NovaSpira Biotherapeutics
NovaSpira Biotherapeutics is a U.S.-based biotech company developing bispecific antibody therapies for GPC3-positive solid tumors, including liver cancer. Its lead candidate, BOS‑342, is currently in Phase 1 clinical development.
Address
ChathamNew Jersey
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)